SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

Microbiol Spectr. 2022;10(3):e0033522.

Stepwise Expansion of Antimicrobial Stewardship Programs and Its Impact on Antibiotic Use and Resistance Rates at a Tertiary Care Hospital in Korea.

, , , , , , , , , , , , ,

제1저자 신동훈 · 교신저자 김홍빈

소속 (7)
  1. Department of Internal Medicine, Seoul National University Bundang Hospitalgrid.412480.b, Seoul National University College of Medicine, Gyeonggi-do, Republic of Korea.
  2. Department of Pharmacy, Seoul National University Bundang Hospitalgrid.412480.b, Gyeonggi-do, Republic of Korea.
  3. Infection Control Center, Seoul National University Bundang Hospitalgrid.412480.b, Gyeonggi-do, Republic of Korea.
  4. Department of Pediatrics, Seoul National University Bundang Hospitalgrid.412480.b, Seoul National University College of Medicine, Gyeonggi-do, Republic of Korea.
  5. Department of Laboratory Medicine, Seoul National University Bundang Hospitalgrid.412480.b, Seoul National University College of Medicine, Gyeonggi-do, Republic of Korea.
  6. Artificial Intelligence and Big-Data Convergence Center, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.
  7. Department of Preventive Medicine, Gachon University College of Medicine, Incheon, Republic of Korea.

Abstract

To optimize antibiotic use, the US CDC has outlined core elements of antimicrobial stewardship programs (ASP). However, they are difficult to implement in limited-resource settings. We report on the successful implementation of a series of ASP with insufficient number of infectious diseases specialists. We retrospectively collected data regarding antibiotic administration and culture results of all patients admitted to a tertiary care teaching hospital, Seoul National University Bundang Hospital (SNUBH), from January 2010 to December 2019. Trends of antibiotic use and antibiotic resistance rates were compared with those from Korean national data. Trend analyses were performed using nonparametric, two-sided, correlated seasonal Mann-Kendall tests. Total antibiotic agent usage has significantly decreased with ASP implementation at SNUBH since 2010. National claim data from tertiary care hospitals have revealed an increase in the use of all broad-spectrum antibiotics except for third-generation cephalosporins (3GC). In contrast, at SNUBH, glycopeptide and fluoroquinolone use gradually decreased, and 3GC and carbapenem use did not significantly change. Furthermore, the rate of colonization with methicillin-resistant Staphylococcus aureus showed a consistently decreasing trend, while that with 3GC- and fluoroquinolone-resistant Escherichia coli significantly increased. Unlike the national rate, the rate of colonization with antibiotic resistant-Klebsiella pneumoniae did not increase and that of 3GC- and fluoroquinolone-resistant Pseudomonas aeruginosa significantly decreased. Stepwise implementation of core ASP elements was effective in reducing antibiotic use despite a lack of sufficient manpower. Long-term multidisciplinary teamwork is necessary for successful and sustainable ASP implementation. IMPORTANCE Antimicrobial stewardship programs aimed to optimize antibiotic use are difficult to implement in limited-resource settings. Our study indicates that stepwise implementation of core antimicrobial stewardship program elements was effective in reducing antibiotic use in a tertiary care hospital despite the lack of sufficient manpower.

Keywords

antibiotic resistanceantibiotic useantimicrobial stewardship programcore elementsmultidisciplinary teamwork

Figures

FIG 1
FIG 1 Trends of antibiotic use (days of therapy [DOT] per 1,000 patient-days) at Seoul National University Bundang Hospital (SNUBH) from 2010 to 2019. (A) Total antibiotic use. (B) Broad-spectrum antibiotic use. NHIS, National Health Insurance Service; Carbapenems (total), all carbapenems; Carbapenems (group 1): ertapenem; Carbapenems (group 2): meropenem, imipenem-cilastatin, and doripenem.
FIG 2
FIG 2 Changes in antibiotic resistance rates at SNUBH from 2010 to 2019. (A) Staphylococcus aureus, (B) Escherichia coli, (C) Klebsiella pneumoniae, (D) Pseudomonas aeruginosa, (E) Acinetobacter baumannii. KARMS: Korean Antimicrobial Resistance Monitoring System. Antimicrobial susceptibility was determined using the disk-diffusion method or the Vitek 2 (bioMérieux, Marcy l’Étoil, France). Each isolate was classified as resistant or nonresistant according to Clinical and Laboratory Standards Institute criteria. Proportions of isolates of each bacteria species which were resistant to the following antibiotics were assessed: oxacillin, third-generation cephalosporins (cefotaxime or ceftazidime), fluoroquinolones (ciprofloxacin), and carbapenems (imipenem). The proportions of carbapenem-resistant E. coli and K. pneumoniae at SNUBH remained less than 1.14%.

그림 출처: PubMed Central 공개 논문 (PMC9241935)

Conflict of interest statement

The authors declare a conflict of interest. This work was supported by the Seoul National University Bundang Hospital Research Fund (grant number 02-2021-024). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

그 밖의 정보
출판 형태
Journal Article, Research Support, Non-U.S. Gov't
저널
Microbiology spectrum · eISSN 2165-0497
전자 출판
2022-04-25
MeSH
Anti-Bacterial Agents / pharmacology / therapeutic use · Antimicrobial Stewardship* / methods · Drug Resistance, Bacterial · Escherichia coli · Fluoroquinolones / pharmacology · Humans · Methicillin-Resistant Staphylococcus aureus* · Republic of Korea · Retrospective Studies · Tertiary Care Centers
Substances
Anti-Bacterial Agents · Fluoroquinolones
참고문헌
40편